Mainz combines world-class research, a strong industry presence and a thriving start-up ecosystem. The city is home to a number of prominent companies, including BioNTech SE, Novo Nordisk and SCHOTT Pharma.

In addition, it is home to nine research institutes and six hospitals, in conjunction with Johannes Gutenberg University. The Life Science Campus Mainz contributes an additional 30 hectares of development space within the city itself.  

Mainz provides direct access to key EU markets and is just 25 minutes from Frankfurt Airport. Germany’s leading financial centre and one of the world’s largest internet exchange points are also close by. 

biomindz supports international companies entering the European market. We provide a comprehensive range of services, including location assessment, regulatory guidance and connections with hospitals, pharmaceutical partners and investors.

The Life Science Campus Mainz offers modern laboratory and office space from 150 m², with LAB 1 to LAB 3 and further developments as Plus Ultra Mainz underway. Companies benefit from GMP-related infrastructure, shared facilities and close proximity to both research and industry, whether they are setting up their first team or scaling their operations.

Mainz offers direct access to leading hospitals and clinical trial centres, including the University Medical Center Mainz. biomindz connects companies directly with relevant clinical partners in Mainz and supports them in establishing new collaborations.

Biotech companies in Mainz can benefit from a range of funding opportunities. These include EU funding programmes such as Horizon Europe, national funding from the Federal Ministry of Research, Technology and Space, as well as funding opportunities offered by the State of Rhineland-Palatinate. biomindz helps companies identify suitable programmes and supports them throughout the application process.

We work closely with companies to explore growth and market opportunities across the Frankfurt Rhine-Main-Neckar region, helping them to tap into its innovation ecosystem.

First, we get to know the company before recommending a location or specific solution.

Which partners are needed? What infrastructure is right for the next stage of development? What regulatory, recruitment or timing risks need to be addressed? What would make establishing a European presence genuinely attractive?

Based on these priorities, we will work together to identify where Mainz and the wider Frankfurt and Rhine-Main-Neckar region could offer real value to the company.

We provide tailored, hands-on support throughout the process, including connecting companies with relevant research, clinical and industry partners to identifying suitable infrastructure and growth opportunities, introducing the right local contacts and exploring different options for establishing a presence in the region.